NewGenIvf Group (NIVF) Stock Price, News & Analysis

Company Overview

NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.

Key Stats

• Today's Range: $0.27 to $0.29
• 50-Day Range: $0.28 to $2.58
• 52-Week Range: $0.26 to $65.60
• Volume: 382,076 shs
• Average Volume: 938,276 shs
• Market Capitalization: $1.50 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

NewGenIvf Group Stock Analysis - MarketRank™

NewGenIvf Group scored higher than 31% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for NewGenIvf Group.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Book Value per Share Ratio

NewGenIvf Group has a P/B Ratio of 0.13. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

20.42% of the float of NewGenIvf Group has been sold short.

Short Interest Ratio / Days to Cover

NewGenIvf Group has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in NewGenIvf Group has recently decreased by 24.97%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

NewGenIvf Group does not currently pay a dividend.

Dividend Growth

NewGenIvf Group does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

20.42% of the float of NewGenIvf Group has been sold short.

Short Interest Ratio / Days to Cover

NewGenIvf Group has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in NewGenIvf Group has recently decreased by 24.97%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: N/A

News Sentiment

NewGenIvf Group has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.63 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for NewGenIvf Group this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for NIVF on MarketBeat in the last 30 days. This is a decrease of -88% compared to the previous 30 days.

MarketBeat Follows

Only 1 people have added NewGenIvf Group to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, NewGenIvf Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

31.80% of the stock of NewGenIvf Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

66.24% of the stock of NewGenIvf Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

NIVF Stock Analysis - Frequently Asked Questions

How have NIVF shares performed this year?

NewGenIvf Group's stock was trading at $8.10 on January 1st, 2025. Since then, NIVF shares have decreased by 96.5% and is now trading at $0.2848.
View the best growth stocks for 2025 here.

When did NewGenIvf Group's stock split?

Shares of NewGenIvf Group reverse split on Tuesday, February 11th 2025. The 1-20 reverse split was announced on Friday, January 31st 2025. The number of shares owned by shareholders was adjusted after the market closes on Monday, February 10th 2025. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of NewGenIvf Group?

Shares of NIVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of NewGenIvf Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that NewGenIvf Group investors own include Tesla (TSLA), SoFi Technologies (SOFI), Snap (SNAP), Rumble (RUM), Proterra (PTRA), Meta Platforms (META) and Amesite (AMST).

Company Calendar

• Today: 4/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Miscellaneous health & allied services, not elsewhere classified
• Sub-Industry: Healthcare
• Current Symbol: NASDAQ:NIVF
• Previous Symbol: NASDAQ:NIVF
• CIK: 1981662
• Web: N/A
• Phone: 65-6818-5796
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $5.14 million
• Price / Sales: 0.29
• Cash Flow: $0.09 per share
• Price / Cash Flow: 3.11
• Book Value: $2.19 per share
• Price / Book: 0.13

Miscellaneous

• Outstanding Shares: 5,271,000
• Free Float: 346,000
• Market Cap: $1.50 million
• Optionable: N/A
• Beta: 0.18